Colorectal carcinomain vitro is more sensitive to 1-hexylcarbamoyl-5-fluorouracil compared with six other antitumor drugs: Carboquone, adriamycin®, mitomycin C, aclacinomycin A, cisplatin, 5-fluorouracil